Cardiovascular ImagingErgonovine test
an attempt to provoke
spasm in susceptible coronary arteries by
intravenous administration of increasing doses of ergonovine maleate. This ergot alkaloid stimulates alpha adrenergic and serotoninergic receptors producing vasoconstriction. It is usually administered in a dose of 0.050.40 mg. It produces coronary arterial
spasm in arterial segments
prone to develop spontaneous
spasm as the cause of angina, usually variant or
Prinzmetals variant angina.
Spasm may be induced in an apparently normal
artery or at the site of a fixed atherosclerotic
stenosis. While this test is usually done during coronary
angiography in order to document the
spasm (
Fig.1), it has also been applied in the coronary care unit where a positive test is indicated by the onset of angina and ST segment elevation. The induced
spasm is reversed with
intravenous or intracoronary injection of nitroglycerin.
CBH
To view high resolution images,
please register first.
Click
here
to register.
Already registered? Enter your e-mail in the window below.Re-registerFig.1
Selective right coronary arteriograms in the left anterior oblique projection show severe stenosis in the artery induced by ergonovine (ERG) (left) and resolution of the spasm after nitroglycerin (NTG) (right).
 | |
Ergonovine test, Fig.1 | |